| ADALIMUMAB |
Humira® |
AbbVie Pty Ltd |
|
Mar 2013 |
|
| ALGLUCOSIDASE ALFA ALFA-RCH |
Myozyme® |
Genzyme |
|
Mar 2013 |
|
| APIXABAN |
Eliquis® |
Bristol-Myers Squibb Australia Pty Ltd |
|
Mar 2013 |
|
| COBICISTAT |
Tybost® |
Gilead Sciences Pty Limited |
|
Mar 2013 |
|
| COBICISTAT + ELVITEGRAVIR + EMTRICITABINE + TENOFOVIR |
Stribild® |
Gilead Sciences Pty Limited |
|
Mar 2013 |
|
| CORIFOLLITROPIN ALFA |
Elonva® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Mar 2013 |
|
| DABIGATRAN ETEXILATE |
Pradaxa® |
Boehringer Ingelheim Pty Ltd |
|
Mar 2013 |
|
| DABRAFENIB |
Tafinlar® |
GlaxoSmithKline Australia Pty Ltd |
|
Mar 2013 |
|
| ECULIZUMAB |
Soliris® |
Alexion Pharmaceuticals Australasia Pty Ltd |
|
Mar 2013 |
|
| ELVITEGRAVIR |
Vitekta® |
Gilead Sciences Pty Limited |
|
Mar 2013 |
|
| ERIBULIN MESILATE |
Halaven® |
Eisai Australia Pty Ltd |
|
Mar 2013 |
|
| EVEROLIMUS |
Afinitor® |
Novartis Pharmaceuticals Australia Pty Limited |
|
Mar 2013 |
|
| FENTANYL CITRATE |
Instanyl® |
Takeda Pharmaceuticals Australia Pty. Ltd. |
|
Mar 2013 |
|
| FERRIC CARBOXYMALTOSE |
Ferinject® |
Vifor Pharma Pty Limited |
|
Mar 2013 |
|
| INFLIXIMAB |
Remicade® |
Janssen-Cilag Pty Ltd |
|
Mar 2013 |
|
| INSULIN DEGLUDEC |
- Tresiba FlexTouch®
- Tresiba Penfill®
|
Novo Nordisk Pharmaceuticals Pty. Limited |
Diabetes mellitus |
Mar 2013 |
|
| LENALIDOMIDE |
Revlimid® |
Celgene Pty Limited |
|
Mar 2013 |
|
| LINAGLIPTIN WITH METFORMIN HYDROCHLORIDE |
Trajentamet® |
Boehringer Ingelheim Pty Ltd |
|
Mar 2013 |
|
| LIRAGLUTIDE |
Victoza® |
Novo Nordisk Pharmaceuticals Pty. Limited |
|
Mar 2013 |
|
| MIFEPRISTONE AND MISOPROSTOL |
|
Marie Stopes (MS) Health |
|
Mar 2013 |
|
| PANITUMUMAB |
Vectibix® |
Amgen Australia Pty Limited |
|
Mar 2013 |
|
| RANIBIZUMAB |
Lucentis® |
Novartis Pharmaceuticals Australia Pty Limited |
|
Mar 2013 |
|
| RISEDRONATE SODIUM |
- Actonel®
- Actonel® EC
- Actonel® Once-a-Month
- Actonel® Combi and Actonel® EC Combi
- Actonel® EC Combi D
|
sanofi-aventis Australia Pty Ltd |
Osteoporosis; Bone mineral density (BMD) |
Mar 2013 |
|
| RIVAROXABAN (PE) |
Xarelto® |
Bayer Australia Ltd |
|
Mar 2013 |
|
| RIVAROXABAN (SPAF) |
Xarelto® |
Bayer Australia Ltd |
|
Mar 2013 |
|
| SAXAGLIPTIN WITH METFORMIN |
Kombiglyze® |
- Bristol-Myers Squibb Australia Pty Ltd
- AstraZeneca Pty Ltd
|
|
Mar 2013 |
|
| TOBRAMYCIN |
TOBI® Podhaler® |
Novartis Pharmaceuticals Australia Pty Limited |
|
Mar 2013 |
|
| VEMURAFENIB |
Zelboraf® |
Roche Products Pty Ltd |
|
Mar 2013 |
|